Literature DB >> 5317798

Fibrinolytic treatment in acute myocardial infarction.

R Heikinheimo, P Ahrenberg, H Honkapohja, E Iisalo, V Kallio, Y Konttinen, O Leskinen, H Mustaniemi, M Reinikainen, L Siitonen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5317798     DOI： 10.1111/j.0954-6820.1971.tb04333.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN： 0001-6101


× No keyword cloud information.
  7 in total

1.  [Influence of a streptokinase-induced fibrinolysis on the extent of the acute experimental myocardial infarction (author's transl)].

Authors:  W Wende; H W Stühlen; J Meyer; W Bleifeld; H Holzhüter; E Wenzel
Journal:  Klin Wochenschr       Date:  1975-08-15

Review 2.  Streptokinase: a review of its clinical pharmacology, mechanism of action and therapeutic uses.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

3.  Streptokinase and myocardial infarction.

Authors:  M Verstraete
Journal:  Br Med J       Date:  1971-12-11

4.  [Coagulation studies and rheological measurements during streptokinase therapy of myocardial infarction (author's transl)].

Authors:  W Theiss; E Volger; A Wirtzfeld; I Keisel; H Blömer
Journal:  Klin Wochenschr       Date:  1980-06-16

5.  Limitation of myocardial infarct size. Present status.

Authors:  S Yusuf; P Sleight
Journal:  Drugs       Date:  1983-05       Impact factor: 9.546

Review 6.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

Review 7.  Coronary thrombolysis for evolving myocardial infarction.

Authors:  J F Spann; S Sherry
Journal:  Drugs       Date:  1984-11       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.